Response to dexamethasone in patients with fluid retention after docetaxel

被引：9

作者：

Chan, S

Winterbottom, L

Gardner, S

机构：

来源：

LANCET | 1996年 / 347卷 / 9013期

关键词：

D O I：

10.1016/S0140-6736(96)91723-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1486 / 1487

页数：2

相关论文

共 3 条

[1] Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer [J].

Hudis, CA ;

Seidman, AD ;

Crown, JPA ;

Balmaceda, C ;

Freilich, R ;

Gilewski, TA ;

Hakes, TB ;

Currie, V ;

Lebwohl, DE ;

Baselga, J ;

Raptis, G ;

Gollub, M ;

Robles, M ;

Bruno, R ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :58-65

[2] PHASE-II TRIAL OF DOCETAXEL IN ADVANCED ANTHRACYCLINE-RESISTANT OR ANTHRACENEDIONE-RESISTANT BREAST-CANCER [J].

RAVDIN, PM ;

BURRIS, HA ;

COOK, G ;

EISENBERG, P ;

KANE, M ;

BIERMAN, WA ;

MORTIMER, J ;

GENEVOIS, E ;

BELLET, RE .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2879-2885

[3] PHASE-II TRIAL OF DOCETAXEL - A NEW, HIGHLY EFFECTIVE ANTINEOPLASTIC AGENT IN THE MANAGEMENT OF PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER [J].

VALERO, V ;

HOLMES, FA ;

WALTERS, RS ;

THERIAULT, RL ;

ESPARZA, L ;

FRASCHINI, G ;

FONSECA, GA ;

BELLET, RE ;

BUZDAR, AU ;

HORTOBAGYI, GN .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2886-2894